Ceftobiprole, vancomycin, teicoplanin and linezolid susceptibility of Gram-positive pathogens from Austria, Germany and Switzerland

F.-J. Schmitz, C. Mackenzie, S. Schubert, J. Schrenzel, N. Günther, S. Decker-Burgard, J. Laeuffer, M.-L. Cassettari & I. Morrissey
Objectives: To evaluate the susceptibility of contemporary Gram-positive pathogens (GPP) causing serious infections in hospitalized patients to ceftobiprole (BPR), a novel cephalosporin with bactericidal activity against both Gram-negative and Gram-positive bacteria, including methicillin-resistant [for full text, please go to the a.m. URL]